Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Price:
43.42
CNY
-0.32%
Market Closed
Market Cap:
¥18.4B
Balance Sheet
Balance Sheet Decomposition
Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co Ltd
Balance Sheet Decomposition is not available for
Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co Ltd
Balance Sheet
Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co Ltd
Currency: CNY
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
263
|
251
|
527
|
752
|
2 009
|
2 441
|
2 074
|
1 736
|
|
| Cash |
0
|
0
|
0
|
0
|
2 009
|
2 441
|
2 074
|
1 736
|
|
| Cash Equivalents |
263
|
251
|
527
|
752
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
781
|
1 434
|
1 238
|
2 428
|
|
| Total Receivables |
70
|
125
|
192
|
346
|
1 897
|
1 051
|
1 211
|
1 220
|
|
| Accounts Receivables |
55
|
104
|
112
|
187
|
247
|
270
|
562
|
691
|
|
| Other Receivables |
15
|
20
|
80
|
159
|
1 649
|
780
|
649
|
529
|
|
| Inventory |
116
|
260
|
199
|
254
|
463
|
671
|
904
|
612
|
|
| Other Current Assets |
10
|
20
|
18
|
39
|
75
|
119
|
95
|
137
|
|
| Total Current Assets |
459
|
656
|
936
|
1 391
|
5 225
|
5 715
|
5 523
|
6 133
|
|
| PP&E Net |
18
|
58
|
65
|
117
|
460
|
696
|
837
|
952
|
|
| PP&E Gross |
18
|
58
|
65
|
117
|
460
|
696
|
837
|
952
|
|
| Accumulated Depreciation |
12
|
18
|
26
|
34
|
86
|
160
|
204
|
270
|
|
| Intangible Assets |
3
|
23
|
46
|
55
|
65
|
78
|
193
|
259
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
414
|
323
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
92
|
307
|
387
|
|
| Other Long-Term Assets |
22
|
27
|
38
|
39
|
63
|
138
|
233
|
250
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
414
|
323
|
|
| Total Assets |
502
N/A
|
764
+52%
|
1 084
+42%
|
1 602
+48%
|
5 812
+263%
|
6 719
+16%
|
7 507
+12%
|
8 304
+11%
|
|
| Liabilities | |||||||||
| Accounts Payable |
37
|
65
|
88
|
117
|
296
|
372
|
402
|
447
|
|
| Accrued Liabilities |
112
|
92
|
125
|
150
|
129
|
112
|
132
|
177
|
|
| Short-Term Debt |
50
|
0
|
15
|
18
|
65
|
0
|
104
|
314
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
49
|
62
|
42
|
63
|
|
| Other Current Liabilities |
34
|
147
|
68
|
106
|
360
|
445
|
611
|
516
|
|
| Total Current Liabilities |
234
|
304
|
296
|
391
|
900
|
992
|
1 291
|
1 518
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
76
|
51
|
68
|
440
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
2
|
8
|
40
|
33
|
|
| Minority Interest |
8
|
6
|
5
|
3
|
23
|
50
|
155
|
138
|
|
| Other Liabilities |
6
|
9
|
27
|
9
|
56
|
66
|
91
|
125
|
|
| Total Liabilities |
247
N/A
|
319
+29%
|
328
+3%
|
403
+23%
|
1 057
+162%
|
1 166
+10%
|
1 646
+41%
|
2 254
+37%
|
|
| Equity | |||||||||
| Common Stock |
48
|
49
|
360
|
360
|
424
|
424
|
424
|
424
|
|
| Retained Earnings |
207
|
347
|
371
|
813
|
1 486
|
2 283
|
2 701
|
2 952
|
|
| Additional Paid In Capital |
0
|
49
|
26
|
26
|
2 846
|
2 846
|
2 846
|
2 817
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
110
|
145
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Equity |
255
N/A
|
445
+75%
|
756
+70%
|
1 199
+59%
|
4 755
+297%
|
5 552
+17%
|
5 861
+6%
|
6 050
+3%
|
|
| Total Liabilities & Equity |
502
N/A
|
764
+52%
|
1 084
+42%
|
1 602
+48%
|
5 812
+263%
|
6 719
+16%
|
7 507
+12%
|
8 304
+11%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
48
|
49
|
360
|
360
|
424
|
424
|
422
|
421
|
|
Switch to:
Switch to:
See Also
Discover More
